OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma
Toshiki Terao, Takeshi Yamashita, Ami Fukumoto, et al.
International Journal of Hematology (2022) Vol. 115, Iss. 5, pp. 737-747
Open Access | Times Cited: 11
Toshiki Terao, Takeshi Yamashita, Ami Fukumoto, et al.
International Journal of Hematology (2022) Vol. 115, Iss. 5, pp. 737-747
Open Access | Times Cited: 11
Showing 11 citing articles:
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, et al.
Leukemia (2023) Vol. 37, Iss. 6, pp. 1175-1185
Open Access | Times Cited: 33
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, et al.
Leukemia (2023) Vol. 37, Iss. 6, pp. 1175-1185
Open Access | Times Cited: 33
Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis
Noppacharn Uaprasert, Palada Pitakkitnukun, Nuanrat Tangcheewinsirikul, et al.
Blood Cancer Journal (2022) Vol. 12, Iss. 12
Open Access | Times Cited: 17
Noppacharn Uaprasert, Palada Pitakkitnukun, Nuanrat Tangcheewinsirikul, et al.
Blood Cancer Journal (2022) Vol. 12, Iss. 12
Open Access | Times Cited: 17
Examining the immunological responses to COVID-19 vaccination in multiple myeloma patients: a systematic review and meta-analysis
Hamid Harandi, Parisa Fallahtafti, Amirali Karimi, et al.
BMC Geriatrics (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Hamid Harandi, Parisa Fallahtafti, Amirali Karimi, et al.
BMC Geriatrics (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Antibody and T‐cell responses by ultra‐deep T‐cell receptor immunosequencing after COVID ‐19 vaccination in patients with plasma cell dyscrasias
Alfred Chung, Barbara L. Banbury, Marissa Vignali, et al.
British Journal of Haematology (2022) Vol. 199, Iss. 4, pp. 520-528
Open Access | Times Cited: 7
Alfred Chung, Barbara L. Banbury, Marissa Vignali, et al.
British Journal of Haematology (2022) Vol. 199, Iss. 4, pp. 520-528
Open Access | Times Cited: 7
Antibody status following booster vaccination against SARS‐CoV ‐2 virus in patients with haematologic malignancies
Daisuke Ikeda, Toshiki Terao, Ami Fukumoto, et al.
British Journal of Haematology (2022) Vol. 200, Iss. 5, pp. 568-572
Open Access | Times Cited: 7
Daisuke Ikeda, Toshiki Terao, Ami Fukumoto, et al.
British Journal of Haematology (2022) Vol. 200, Iss. 5, pp. 568-572
Open Access | Times Cited: 7
COVID-19 vaccine immune response in patients with plasma cell dyscrasia: a systematic review
Unaiza Faizan, Lakshmi G. Nair, Maroun Bou Zerdan, et al.
Therapeutic Advances in Vaccines and Immunotherapy (2023) Vol. 11
Open Access | Times Cited: 2
Unaiza Faizan, Lakshmi G. Nair, Maroun Bou Zerdan, et al.
Therapeutic Advances in Vaccines and Immunotherapy (2023) Vol. 11
Open Access | Times Cited: 2
One Year Duration of Immune Response Following a 3rd Booster Dose of mRNA Vaccine Against COVID‐19 in 292 Patients With Hematological Malignancies in University Hospital Ostrava, Czech Republic
Ondrej Šušol, Barbora Šušolová, Ondřej Klempíř, et al.
Cancer Medicine (2024) Vol. 13, Iss. 24
Open Access
Ondrej Šušol, Barbora Šušolová, Ondřej Klempíř, et al.
Cancer Medicine (2024) Vol. 13, Iss. 24
Open Access
Humoral and cellular immune response to second and third severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with plasma cell dyscrasia
Tomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki, et al.
Cancer Medicine (2023) Vol. 12, Iss. 12, pp. 13135-13144
Open Access | Times Cited: 1
Tomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki, et al.
Cancer Medicine (2023) Vol. 12, Iss. 12, pp. 13135-13144
Open Access | Times Cited: 1
Antibody response after third dose of COVID-19 mRNA vaccination in allogeneic hematopoietic stem cell transplant recipients is comparable to that in healthy counterparts
Erina Takagi, Seitaro Terakura, Hidetsugu Fujigaki, et al.
International Journal of Hematology (2023) Vol. 118, Iss. 4, pp. 462-471
Closed Access
Erina Takagi, Seitaro Terakura, Hidetsugu Fujigaki, et al.
International Journal of Hematology (2023) Vol. 118, Iss. 4, pp. 462-471
Closed Access
Comparative analysis of humoral responses to BNT162b2 vaccine among patients with hematologic disorders and organ transplant recipients.
Hideyuki Nakazawa, Kaoko Sakai, Yuriko Sudo, et al.
Transplant Immunology (2022) Vol. 75, pp. 101713-101713
Open Access
Hideyuki Nakazawa, Kaoko Sakai, Yuriko Sudo, et al.
Transplant Immunology (2022) Vol. 75, pp. 101713-101713
Open Access
Prevalence and clinical outcome of Omicron breakthrough infection in patients with hematologic disease: a prospective observational cohort study
Kentaro Narita, Daisuke Ikeda, Mizuki Seki, et al.
Research Square (Research Square) (2022)
Open Access
Kentaro Narita, Daisuke Ikeda, Mizuki Seki, et al.
Research Square (Research Square) (2022)
Open Access
